Strategic Expansion Target collaboration discussions with their two global locations (Menlo Park and Shanghai) to offer joint development programs around liquid biopsy platforms, expanding customer reach through co-sponsored research and multi-region clinical studies.

Clinical Enablement Position precision oncology services and the Accu-Scan Panel as a gateway for pharma and hospitals seeking early cancer detection capabilities, offering integration with existing lab workflows and clinical decision support.

Funding & Growth Leverage their recent $40M Series B and ongoing expansion to present scalable instrumentation, data analytics, and cloud-based pipeline solutions that fit their mid-sized velocity and growth ambitions.

Tech Backbone Highlight opportunities to optimize deployment and data management using their cloud and DevOps stack (AWS, Terraform, Docker, Kubernetes, GitHub) for secure, compliant, scalable research workflows and partner ecosystems.

Strategic Partnerships Explore alliances with contract research organizations, diagnostic developers, and oncology-focused biotech firms (aligned with similar peers or competitors) to broaden testing panels, regulatory assent, and market access.